May 26, 2020 / 12:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Atara Biotherapeutics European Academy of Neurology ATA188 Data Conference Call. I would now like to turn the conference over to your host, Eric Hyllengren, Vice President of Investor Relations and Finance. You may begin.
Eric Hyllengren - Atara Biotherapeutics, Inc. - Head of IR & Finance
Thank you, operator. Good morning, everyone, and welcome to the Atara European Academy of Neurology ATA188 Data Conference Call. Earlier this morning, we issued a press release reporting positive data from our ongoing Phase Ia clinical trial of ATA188 presented at EAN. This press release and the slides we will be presenting during this call are available in the Investors and Media section of atarabio.com.
I'm joined on the call today by Pascal Touchon, President and Chief Executive Officer; Dr. Jakob Dupont, Executive Vice President and Global Head of Research and Development; and Dr. AJ Joshi, Chief Medical Officer. Also with us today is Dr. Larry Steinman, Professor of Neurology and Neurological Sciences,
Atara Biotherapeutics, Inc. - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot